Correction (DOI:10.1016/j.ajo.2007.11.011);Serum and Tear Levels of Nerve Growth Factor in Diabetic Retinopathy Patients

American Journal of Ophthalmology

Volumn 145, Issue 3, 2008, Pages 432-437

  Park, Kyoung Soo ^a   Kim, Sung Soo ^a   Kim, Jae Chan ^b   Kim, Hyeon Chang ^a   Im, Yong Sun ^a   Ahn, Chul Woo ^a   Lee, Hyung Keun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; NERVE GROWTH FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LACRIMAL FLUID LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNIVERSITY HOSPITAL;

EID: 39049151766     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.10.011     Document Type: Erratum

References (21)

1. Frank R.N. Diabetic retinopathy. N Engl J Med 350 (2004) 48-58
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
4. Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., and Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19 (1996) 514-520
5. Calza L., Giardino L., Giuliani A., Aloe L., and Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci U S A 98 (2001) 4160-4165
6. Cantarella G., Lempereur L., Presta M., et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16 (2002) 1307-1309
7. Graiani G., Emanueli C., Desortes E., et al. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 47 (2004) 1047-1054
8. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS Report No. 10. Ophthalmology 98 (1991) 786-806
9. Lee H.K., Lee K.S., Kim H.C., Lee S.H., and Kim E.K. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis. Am J Ophthalmol 139 (2005) 965-971
10. Azar S.T., Major S.C., and Safieh-Garabedian B. Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus. Brain Behav Immun 13 (1999) 361-366
11. Heese K., Beck K.F., Behrens M.H., et al. Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells. Biochem Pharmacol 65 (2003) 293-301
12. Dyck P.J., Dyck P.J., Larson T.S., O'Brien P.C., and Velosa J.A. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 23 (2000) 510-517
13. Matsuda H., Koyama H., Sato H., et al. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 187 (1998) 297-306
14. Emanueli C., Salis M.B., Pinna A., Graiani G., Manni L., and Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106 (2002) 2257-2262
15. Chatterjee P.R., De S., Datta H., et al. Estimation of tear glucose level and its role as a prompt indicator of blood sugar level. J Indian Med Assoc 101 (2003) 481-483
16. Kaji Y., Amano S., Usui T., et al. Advanced glycation end products in Descemet's membrane and their effect on corneal endothelial cell. Curr Eye Res 23 (2001) 469-477
17. Rosenbaum T., Vidaltamayo R., Sanchez-Soto M.C., Zentella A., and Hiriart M. Pancreatic beta cells synthesize and secrete nerve growth factor. Proc Natl Acad Sci U S A 95 (1998) 7784-7788
18. Tuveri M., Generini S., Matucci-Cerinic M., and Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 356 (2000) 1739-1740
19. Hosotani H., Ohashi Y., Yamada M., and Tsubota K. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. Am J Ophthalmol 119 (1995) 288-294
20. Nyengaard J.R., Ido Y., Kilo C., and Williamson J.R. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes 53 (2004) 2931-2938
21. Dogru M., Katakami C., and Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 108 (2001) 586-592